“IMPACT OF INSULIN RESISTANCE ON THE CENTRAL NERVOUS SYSTEM”

Authors

  • Khonzoda Kirgizboyeva Faculty of Pharmacy, Management, and Biomedical Sciences, Department of Biomedical Engineering and Nursing, Tashkent State Medical University, Nursing Program, Tashkent, Uzbekistan Author
  • Gozal Davidova Faculty of Pharmacy, Management, and Biomedical Sciences, Department of Biomedical Engineering and Nursing, Tashkent State Medical University, Nursing Program, Tashkent, Uzbekistan Author

Keywords:

Insulin resistance, central nervous system, neuroinflammation

Abstract

Insulin resistance is one of the most widespread metabolic disorders in modern medicine and has traditionally been studied primarily in association with type 2 diabetes mellitus and cardiovascular diseases. In recent years, scientific research has demonstrated that insulin resistance also exerts adverse effects on the functioning of the central nervous system. This article analyzes the mechanisms through which insulin resistance affects the central nervous system, particularly disruptions in insulin signaling pathways, neuroinflammation, oxidative stress, and alterations associated with neurotransmitter imbalance. The findings indicate that early detection of insulin resistance and its management based on a comprehensive therapeutic approach are of critical importance in preventing central nervous system–related complications.

References

1. Аметов, А. С. Сахарный диабет 2 типа: современные представления о патогенезе и лечении. Moscow: ГЭОТАР-Медиа, 2019. 368 p.

2. American Diabetes Association (ADA). Standards of Medical Care in Diabetes. Available at: www.diabetes.org

3. Dedov, I. I., Shestakova, M. V. Modern aspects of the pathogenesis of insulin resistance // Diabetes Mellitus. 2021. Vol. 24, No. 2. P. 89–97.

4. Фадеев, В. В., Андреев, А. Ю. Инсулинорезистентность: клинические аспекты и подходы к терапии // Эндокринология. 2019. Vol. 25, No. 4. P. 12–18.

5. Ҳақбердиев, М. М., ed. N. N. Nigmatov; compilers: L. A. Alimova, S. A. Begmanov, Y. U. Zokirov, O. I. Yusupova. Tashkent, 2009.

6. IDF Diabetes Atlas. International Diabetes Federation. Available at: www.diabetesatlas.org

7. Khan, M. A., Hashim, M. J., King, J. A., Govender, R. D., Mustafa, H., Al Kaabi, J. Epidemiology of type 2 diabetes – global burden of disease and forecasted trends // Journal of Epidemiology and Global Health. 2020. Vol. 10, Issue 1. P. 107–111.

8. Ковальчук, А. Ю., Тищенко, И. А. Genetic and epigenetic aspects of insulin resistance in type 2 diabetes // Russian Journal of Diabetes. 2022. Vol. 25, No. 3. P. 23–30.

9. Кулагина, Л. В. Clinical and laboratory diagnostics of type 2 diabetes // Lechashchiy Vrach. 2021. No. 6. P. 56–61.

10. Мельниченко, Г. А. Endocrinology: National Guide, ed. I. I. Dedov, G. A. Mel’nichenko. 2nd ed. Moscow: ГЭОТАР-Медиа, 2020. 864 p.

11. Olefsky, J. M., Glass, C. K. Macrophages, inflammation, and insulin resistance // Annual Review of Physiology. 2010. Vol. 72. P. 219–246.

12. Saltiel, A. R., Kahn, C. R. Insulin signalling and the regulation of glucose and lipid metabolism // Nature. 2001. Vol. 414. P. 799–806.

13. World Health Organization (WHO). Diabetes: Fact sheet. Available at: www.who.int/news-room/fact-sheets/detail/diabetes

14. Зимня, Я. Е. Oxidative stress and insulin resistance: new insights // Klinicheskaya Meditsina. 2020. Vol. 98, No. 1. P. 45–50.

Downloads

Published

2026-03-13